Theratechnologies Incis A Biopharmaceutical Company Based In Montrealspecializing In Innovative Therapies For Hiv And Oncologythe Company Focuses On Developing And Commercializing Targeted Treatmentsparticularly For Orphan Medical Conditionsit Markets Fda Approved Therapies And Has An Active Pipeline Aimed At Addressing Unmet Medical Needs Among Its Marketed Products Are Egrifta Svwhich Helps Reduce Excess Abdominal Fat In Hiv Patients With Lipodystrophyand Trogarzoa Treatment For Heavily Treatment Experienced Patients With Multidrug Resistant Hivthe Company Is Also Advancing Several Pipeline Developmentsincluding Trogarzo Iv Slow Push For Simplified Hiv Therapy Administrationegrifta F8 For Non Alcoholic Steatohepatitis In Hiv Patientsand Targeted Therapies For Aggressive Cancers Like Triple Negative Breast Cancer And Ovarian Cancer Theratechnologies Serves Hiv Patients Facing Complications And Oncology Patients With Aggressive Cancersworking Closely With Healthcare Providers To Manage Complex Casesthe Company Continues To Growas Evidenced By Its Recent Positive Financial Performance And Ongoing Clinical Research Initiatives
United States
